Anixa Biosciences
ANIX
ANIX
16 hedge funds and large institutions have $4.32M invested in Anixa Biosciences in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$391K |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.52M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$663K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$231K |
| 5 |
5
Morgan Stanley
New York
|
$11K |
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$6K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$16K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$29K |
